Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Soquelitinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corvus Presents Additional Data on Soquelitinib for T Cell Lymphoma
    Corvus Presents Additional Data on Soquelitinib for T Cell Lymphoma

    20 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/20/3046156/0/en/Corvus-Pharmaceuticals-Announces-Presentation-of-Additional-Data-from-the-Phase-1-1b-Clinical-Trial-of-Soquelitinib-for-Patients-with-T-Cell-Lymphoma.html

    GLOBENEWSWIRE
    20 Mar 2025
    Share Share
    Corvus Starts Ph2 Trial Of Soquelitinib For ALPS Patients
    Corvus Starts Ph2 Trial Of Soquelitinib For ALPS Patients

    12 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/12/3041299/0/en/Corvus-Pharmaceuticals-Announces-Initiation-of-Phase-2-Clinical-Trial-of-Soquelitinib-for-Patients-with-Autoimmune-Lymphoproliferative-Syndrome-ALPS.html

    GLOBENEWSWIRE
    12 Mar 2025
    Share Share
    Corvus Shares Phase 1 Soquelitinib Data For Atopic Dermatitis
    Corvus Shares Phase 1 Soquelitinib Data For Atopic Dermatitis

    13 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/13/3008374/0/en/Corvus-Pharmaceuticals-Announces-Data-from-Cohort-2-of-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    13 Jan 2025
    Share Share
    Corvus Pharmaceuticals Announces Data from Soquelitinib Trial
    Corvus Pharmaceuticals Announces Data from Soquelitinib Trial

    18 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/18/2998957/0/en/Corvus-Pharmaceuticals-Announces-Interim-Data-from-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    18 Dec 2024
    Share Share
    Corvus Pharma Initiates Phase 3 Trial Of Soquelitinib For PTCL
    Corvus Pharma Initiates Phase 3 Trial Of Soquelitinib For PTCL

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943658/0/en/Corvus-Pharmaceuticals-Initiates-Registrational-Phase-3-Clinical-Trial-of-Soquelitinib-for-Patients-with-Relapsed-Refractory-Peripheral-T-Cell-Lymphoma.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    Corvus Pharma Reports Q2 2024 Results And Business Update
    Corvus Pharma Reports Q2 2024 Results And Business Update

    06 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/06/2925408/0/en/Corvus-Pharmaceuticals-Provides-Business-Update-and-Reports-Second-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    06 Aug 2024
    Share Share